Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 45, Issue 4, Pages 632-640
Publisher
Springer Science and Business Media LLC
Online
2019-12-16
DOI
10.1038/s41386-019-0589-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia
- (2019) Nina V. Kraguljac et al. SCHIZOPHRENIA RESEARCH
- Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
- (2019) Anna M. Wang et al. JAMA Psychiatry
- Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
- (2019) Kirsten B. Bojesen et al. PSYCHOLOGICAL MEDICINE
- Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients
- (2018) Camilo de la Fuente-Sandoval et al. BIOLOGICAL PSYCHIATRY
- Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)
- (2018) A. Egerton et al. MOLECULAR PSYCHIATRY
- Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study
- (2018) Eric Plitman et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
- (2018) JP Kesby et al. Translational Psychiatry
- Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study
- (2018) Yusuke Iwata et al. BIOLOGICAL PSYCHIATRY
- Midcingulate cortex: Structure, connections, homologies, functions and diseases
- (2016) Brent A. Vogt JOURNAL OF CHEMICAL NEUROANATOMY
- Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
- (2016) Euitae Kim et al. NEUROPSYCHOPHARMACOLOGY
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
- (2015) M. E. Goldstein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Simultaneous quantification of glutamate and glutamine by J-modulated spectroscopy at 3 Tesla
- (2015) Yan Zhang et al. MAGNETIC RESONANCE IN MEDICINE
- Advanced processing and simulation of MRS data using the FID appliance (FID-A)-An open source, MATLAB-based toolkit
- (2015) Robin Simpson et al. MAGNETIC RESONANCE IN MEDICINE
- Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction
- (2015) Eric Plitman et al. SCHIZOPHRENIA BULLETIN
- Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
- (2015) Elias Mouchlianitis et al. SCHIZOPHRENIA BULLETIN
- Japanese versions of the Executive Interview (J-EXIT25) and the Executive Clock Drawing Task (J-CLOX) for older people
- (2014) Teruyuki Matsuoka et al. INTERNATIONAL PSYCHOGERIATRICS
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis
- (2013) Camilo de la Fuente-Sandoval et al. JAMA Psychiatry
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia
- (2011) Naoko Aoyama et al. BRITISH JOURNAL OF PSYCHIATRY
- Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy
- (2011) S. Andrea Wijtenburg et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
- (2011) Camilo de la Fuente-Sandoval et al. NEUROPSYCHOPHARMACOLOGY
- Treatment resistant schizophrenia and response to antipsychotics: A review
- (2011) Takefumi Suzuki et al. SCHIZOPHRENIA RESEARCH
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now